Electrospun PCL membranes for localized drug delivery and bone regeneration

BMC Biotechnology

Table 2 Release behavior of therapeutic agents in PCL-based membranes analyzed by UV-Vis spectrophotometry

	Concentration (mgL) (2 h)	Absorption (2 h)	Concentration (mg/L) (4 h)	Absorption (4 h)
10% PCL-0.5% Pentoxifylline	2.020	0.500	2.440	0.620
10% PCL-1% Pentoxifylline	9.880	0.610	10.950	0.676
10% PCL-2% Pentoxifylline	77.460	0.590	41.470	0.320
10% PCL-0.5% NaF	0.016	0.004	0.524	0.129
10% PCL-1% NaF	0.097	0.024	0.754	0.186
10% PCL-2% NaF	0.164	0.041	0.781	0.193
10% PCL-0.5% Carrageenan	0.230	0.057	0.496	0.124
10% PCL-1% Carrageenan	0.236	0.059	0.670	0.167
10% PCL-2% Carrageenan	0.027	0.068	0.772	0.193

ISSN: 1472-6750